Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × Immunohistochemistry × Clear all

NCT01155583 2020-11-16

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

45 enrolled 20 charts

Multiple Myeloma